Credit Suisse analyst Dan Leonard initiates coverage on Fulgent Genetics (NASDAQ:FLGT) with a Outperform rating and announces Price Target of $65.
Mark Zuckerberg Dropped From FTC Lawsuit After Reaching Agreement On VR Startup
The U.S. Federal Trade Commission, which sought to prevent Meta Platforms Inc (NASDAQ: META) CEO Mark Zuckerberg from purchasing a virtual reality startup through legal action, is reportedly dropping the executive from its lawsuit.
